Glass House CEO Kyle Kazan urges cannabis activists to "reach out to their Congress, send an email, call the President. People are literally sitting in prison for cannabis. And that makes absolutely no sense in this country."
Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called "a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets." "Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world," Sosiak said. "As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis."
Tim Seymour discussed the impact of changing legal frameworks in the cannabis industry, emphasizing the need for adaptable business models and caution in investments.